Beam Therapeutics, Inc. (BEAM)
26.52
+1.00
(+3.92%)
USD |
NASDAQ |
Mar 06, 16:00
26.27
-0.25
(-0.94%)
After-Hours: 20:00
Beam Therapeutics EPS Diluted (Quarterly) : 2.328 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Intellia Therapeutics, Inc. | -0.8263 |
| Twist Bioscience Corp. | -0.4995 |
| Pacific Biosciences of California, Inc. | -0.1337 |
| Ionis Pharmaceuticals, Inc. | -1.414 |
| Stryker Corp. | 2.197 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 244.30M |
| Revenue (Quarterly) | 114.11M |
| Total Expenses (Quarterly) | -130.19M |
| Enterprise Value | 1.508B |
| Gross Profit Margin (Quarterly) | 95.03% |
| Earnings Yield | -3.83% |
| Normalized Earnings Yield | -3.958 |